Yanchen Liang

Yanchen Liang


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2023 in Experimental Biology and Medicine
Verified
Journal Article
Closed access
CYChuanjian Yuan
Chuanjian Yuan
RFRong Fan
Rong Fan
KZKai Zhu
Kai Zhu
YWYutong Wang
Yutong Wang
WXWenpeng Xie
Wenpeng Xie
YLYanchen Liang
Yanchen Liang
Curcumin, an antitumor agent, has been shown to inhibit cell growth and metastasis in osteosarcoma. However, there is no evidence of curcumin and its regulation of cell ferroptosis and nuclear factor E2–related factor 2 (Nrf2)/glutathione peroxidase 4 (GPX4) signaling pathways in osteosarcoma. This study aimed to investigate the effects of curcumin on osteosarcoma both in vitro and in vivo. To explore the effects and mechanisms of curcumin on osteosarcoma, cells (MNNG/HOS and MG-63) and xenograft mice models were established. Cell viability, cell apoptosis rate, cycle distribution, cell migration, cell invasion, reactive oxygen species, malonaldehyde and glutathione abilities, and protein levels were detected by cell counting kit-8, flow cytometry, wound healing, transwell assay, respectively. Nrf2 and GPX4 expressions were detected using an immunofluorescence assay. Nrf2/GPX4-related protein levels were detected using western blotting. The results showed that curcumin effectively decreased cell viability and increased apoptosis rate. Meanwhile, curcumin inhibited tumor volume in the xenograft model, and Nrf2/GPX4-related protein levels were also altered. Interestingly, the effects of curcumin were reversed by liproxstatin-1 (an effective inhibitor of ferroptosis) and bardoxolone-methyl (an effective activator of Nrf2). Our results indicate that curcumin has therapeutic effects on osteosarcoma cells and a xenograft model by regulating the expression of the Nrf2/GPX4 signaling pathway.

28 January 2025 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
LSLei Sun
Lei Sun
JZJinhao Zhang
Jinhao Zhang
ZXZhikai Xiahou
Zhikai Xiahou
ZZZhenzhen Zhao
Zhenzhen Zhao
YLYanchen Liang
Yanchen Liang
Background: Osteosarcoma (OS) is one of the most common primary malignant bone tumors, primarily originating from mesenchymal tissue. It is notorious for its high invasiveness, high disability rate, high mortality rate, and poor prognosis. In most primary and metastatic malignant tumors, bone destruction can promote cancer progression, which is closely related to osteoclast activation and the imbalance between osteoblasts and osteoclasts. A large number of studies confirmed that osteoclasts are an important part of OS, which play an active role in destroying bone homeostasis and promoting the progress of OS. Therefore, we conducted a detailed study of osteoclasts at the single cell level, aiming to find new OS therapeutic targets to prevent tumor progression and local spread.Methods: We analyzed the single-cell sequencing data of OS patients and usedMonocle2, Cytotrace, and Slingshot software to analyze the pseudo-sequential trajectory during OS progression. CellChat was used to reveal the communication between cells. PySCENIC was used to identify active transcription factors in osteoclasts. Finally, we further demonstrated the results by RT-qPCR analysis, CCK-8 assay, wound healing assay, Transwell assay, etc.Results: Through the analysis of single-cell sequencing data in OS, we identified a highly specific subgroup, C2MKI67+ Osteoclast. The key signaling pathway APP and the top 1 transcription factor PPARG in this subgroup played essential roles in osteoclast proliferation and differentiation. Given the pivotal role of osteoclasts in OS progression, we speculated that these signaling pathways and transcription factors could emerge as novel therapeutic targets, offering innovative strategies for OS treatment.Conclusion: This study enhanced our understanding of OS and osteoclasts through scRNA-seq. Furthermore, we discovered that PPARG amplifies osteoclast activation and proliferation, resulting in excessive bone resorption and degradation of the bone matrix, thereby creating a favorable environment for tumor cell proliferation and growth. By innovatively targeting PPARG, it affected osteoclast proliferation and thus affected tumor progression; this work offered new insights and directions for the clinical treatment of OS patients.

22 June 2023 in Journal of Orthopaedic Surgery and Research
Verified
Journal Article
Open access
PDF file
CYChuanjian Yuan
Chuanjian Yuan
YLYanchen Liang
Yanchen Liang
KZKai Zhu
Kai Zhu
WXWenpeng Xie
Wenpeng Xie
Background: Continuous use of glucocorticoids (GCs) has become the primary cause of secondary osteoporosis. Bisphosphonate drugs were given priority over denosumab and teriparatide in the 2017 American College of Rheumatology (ACR) guidelines but have a series of shortcomings. This study aims to explore the efficacy and safety of teriparatide and denosumab compared with those of oral bisphosphonate drugs. Methods: We systematically searched studies included in the PubMed, Web of Science, Embase, and Cochrane library databases and included randomized controlled trials that compared denosumab or teriparatide with oral bisphosphonates. Risk estimates were pooled using both fixed and random effects models. Results: We included 10 studies involving 2923 patients who received GCs for meta-analysis, including two drug base analyses and four sensitivity analyses. Teriparatide and denosumab were superior to bisphosphonates in increasing the bone mineral density (BMD) of the lumbar vertebrae [teriparatide: mean difference [MD] 3.98%, 95% confidence interval [CI] 3.61–4.175%, P = 0.00001; denosumab: MD 2.07%, 95% CI 0.97–3.17%, P = 0.0002]. Teriparatide was superior to bisphosphonates in preventing vertebral fractures and increasing hip BMD [MD 2.39%, 95% CI 1.47–3.32, P < 0.00001]. There was no statistically significant difference between serious adverse events, adverse events, and nonvertebral fracture prevention drugs. Conclusions: Teriparatide and denosumab exhibited similar or even superior characteristics to bisphosphonates in our study, and we believe that they have the potential to become first-line GC-induced osteoporosis treatments, especially for patients who have previously received other anti-osteoporotic drugs with poor efficacy.

1 January 2024 in Human & Experimental Toxicology
Verified
Journal Article
Open access
KZKai Zhu
Kai Zhu
JBJianping Bi
Jianping Bi
QZQingkun Zhang
Qingkun Zhang
YYYifan Yang
Yifan Yang
JLJie Li
Jie Li
YLYanchen Liang
Yanchen Liang
Objects: This study intends to explore the possible mechanisms of curcumin’s action after knee osteoarthritis. Methods: Chondrocytes alone were used to mimic the cellular inflammatory response with interleukin IL-1β. Overexpressing TRPM2 chondrocytes were constructed using cell transfection technique for mechanism verification. The proliferation of chondrocytes was assessed by CCK8 assay, cellular ROS level was detected by flow cytometry, cellular inflammatory factor content was detected by ELISA kit, and molecules of cellular pyroptosis-related signaling pathway were detected by western blot and immunofluorescence. In vivo experiments, a rat knee osteoarthritis model was constructed. Cartilage integrity was assessed by histological analysis, cellular inflammatory factor content was detected by ELISA kit, and cellular pyroptosis-related signaling pathway molecules were detected by western blot and immunohistochemistry. Results: Curcumin targeting the TRPM2/NLRP3 signaling axis significantly inhibited IL-1β induced decrease in cell viability, increase in ROS level, secretion of inflammatory factors such as TNF-α, IL-6, IL-10, etc., as well as decreased the expression of cellular scaffolding-related proteins, such as GSDMD, NLRP3 and pro-caspase-1, etc. ( p < .05). Meanwhile, curcumin targeting the TRPM2/NLRP3 signaling axis also significantly improved the pathological state of cartilage tissue, maintained cartilage integrity, and reduced the secretion of inflammatory factors, and treated osteoarthritis of the knee in rats by mediating cellular pyroptosis. Conclusions: Curcumin can effectively improve the inflammatory response of chondrocytes through the TRPM2/NLRP3 signaling axis in the treatment of osteoarthritis of the knee in rats.

20 May 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
CLChuanlong Liu
Chuanlong Liu
TWTonghao Wang
Tonghao Wang
ZRZhishuai Ren
Zhishuai Ren
JLJi Luo
Ji Luo
ZWZhexiang Wang
Zhexiang Wang
BPBing Peng
Bing Peng
Osteoporosis (OP) is a chronic metabolic bone disease characterised by low bone mass and deterioration of bone microarchitecture as its core pathological features, which predominantly affects the elderly population and postmenopausal women. Macrophages, as key components of the immune system, function in regulating inflammatory responses, tissue repair and immune modulation, and play a pivotal role in the pathogenesis and progression of osteoporosis: their distinct polarisation states can directly influence osteoblast differentiation and bone resorption activity, and the regulation of bone metabolic homeostasis mediated by macrophages has become one of the current research hotspots. Under specific stimuli, macrophages can polarise into the classically activated M1 phenotype with pro-inflammatory activity and the alternatively activated M2 phenotype with anti-inflammatory and reparative functions, and the imbalance in the M1/M2 polarisation ratio is one of the pathological factors contributing to the development and progression of osteoporosis ( Figure 1 ); accumulating evidence indicates that abnormal shifts in macrophage polarisation phenotypes may disrupt the normal bone remodeling process and break the homeostatic balance of bone metabolism, therefore modulating the M1/M2 polarisation balance holds great significance for the treatment and prevention of osteoporosis, and the dynamic balance of M1/M2 macrophage polarisation also exerts a critical effect in various pathological conditions including tumours, cardiovascular diseases and immune disorders. This article systematically reviews the molecular mechanisms underlying the regulation of bone metabolism by macrophage polarisation, with a focus on summarising the advances in macrophage-targeted therapeutic strategies for osteoporosis, including the polarisation-regulating effects of conventional anti-osteoporotic drugs and the applications of emerging technologies such as nano delivery and cellular intervention, aiming to facilitate the development of more targeted and efficacious therapeutic strategies for osteoporosis based on macrophage polarisation and provide theoretical support and practical directions for addressing the public health challenge of osteoporosis against the backdrop of global ageing.

20 April 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
CSChengcheng Song
Chengcheng Song
TCTaowu Chen
Taowu Chen
SYSijia Yu
Sijia Yu
THTianjiao Huang
Tianjiao Huang
TCTian-Xin Chen
Tian-Xin Chen
YLYanchen Liang
Yanchen Liang
Background: Multiple myeloma (MM) typically evolves from monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM). Its progression is accompanied by significant tumor heterogeneity and immune microenvironment remodeling, and MM remains largely incurable despite therapeutic advances. Elucidating cellular heterogeneity and regulatory mechanisms involved in disease progression is critical for understanding MM pathogenesis. Methods: Single-cell RNA sequencing (scRNA-seq) provides important support for systematically elucidating the molecular mechanisms and immune regulatory pathways associated with the progression of MM. The scRNA-seq datasets from healthy donors (HD), MGUS, SMM, and MM patients were obtained from the GEO database to analyze plasma cell transcriptional heterogeneity within the bone marrow microenvironment. Plasma cell differentiation trajectories were inferred using pseudotime analysis, and intercellular communication and transcription factor regulatory networks were predicted using CellChat and SCENIC analyses. In addition, functional validation of ELK3 was performed in vitro using MM cell lines RPMI 8226 and U266. Results: In this work, we used scRNA-seq to thoroughly evaluate the heterogeneity of MM. We identified a tumor-associated plasma cell subtype, C4 TTN+ plasma cell subtype, which was predominant in SMM and MM and was significantly enriched throughout the intermediate and final phases of differentiation. We hypothesized that C4 TTN+ plasma cell subtype may be associated with the progression of MM. We also found that the TGFb signaling pathway played a key role in the interaction between C4 TTN+ plasma cell subtype and various cell types within the TME. Furthermore, in vitro experiments validated the positive regulatory effects of ELK3 on plasma cell proliferation, migration, and cell viability in MM. Conclusion: In summary, this study, based on scRNA-seq analysis, identified a C4 TTN+ plasma cell subtype potentially associated with ELK3 . This subtype may be associated with progression and immune evasion in MM, thereby providing a potential new direction for targeted immunotherapeutic strategies in MM.